Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant

Clinical trial NCT05839119 · TERMINATED

Trial details

NCT number: NCT05839119
Sponsor: Brown University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Urothelial Carcinoma Bladder Androgen Receptor Positive

Start date: 2023-10-02
Primary completion: 2025-07-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.